Atrovent
Product Images NDC 50090-0961

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Atrovent (NDC 50090-0961). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atrovent Figure 1 (Atroventhfa Fig1)

The text appears to be a comparison of the effects of different doses and types of ipratropium bromide inhalers on FEVI (forced expiratory volume in one second) over time. The measurements were taken at hourly intervals for 8 hours after drug administration on two separate days, with the first day serving as a control with a placebo.*

FDA Label Image

Atrovent Diag. 1 (Atroventhfa Pic1)

FDA Label Image

Atrovent Diag. 2 (Atroventhfa Pic2)

FDA Label Image

Atrovent Diag. 3 (Atroventhfa Pic3)

FDA Label Image

Atrovent Diag. 4 (Atroventhfa Pic4)

FDA Label Image

Atrovent Diag. 5 (Atroventhfa Pic5)

FDA Label Image

Atrovent Diag. 6 (Atroventhfa Pic6)

FDA Label Image

Atrovent Diag. 7a (Atroventhfa Pic7a)

FDA Label Image

Atrovent Diag. 7b (Atroventhfa Pic7b)

FDA Label Image

Atroventhfa-structure (Atroventhfa Structure)

FDA Label Image

Label Image (Lbl500900961)

ATROVENT HFA is an inhalation aerosol with a net weight of 12.9 grams and contains 200 doses.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.